Cipla Ltd shares continued their upward momentum, rising 2.53% to trade at ₹1,476.6 as of 12:44 IST on the NSE. According to reports from Business Standard, the pharmaceutical stock has now gained for five consecutive sessions, demonstrating sustained investor interest. The stock's performance stands in contrast to the broader market, with the benchmark NIFTY declining 0.46% to 23,944.45 and the Sensex falling 0.5% to 76,716.34 during the same period.
As reported by Business Standard, Cipla has demonstrated strong monthly performance with 6.21% gains over the past month. The company's sector performance shows the Nifty Pharma index rising 4.4% in the same period, currently trading at 24,969.5 with a 1.25% daily gain. Despite this recent strength, the stock remains 1.95% down over the past year, significantly outperforming the NIFTY's 6.16% decline and the Nifty Pharma's 14.71% drop during the same period.
According to Business Standard, trading volume reached 20.59 lakh shares today, exceeding the daily average of 15.8 lakh shares recorded over the last month. The benchmark June futures contract for Cipla shares is trading at ₹1,472.9, representing a 2.22% gain on the day. The stock's price-to-earnings ratio stands at 33.8 based on trailing twelve months earnings ending March 2026.
